Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19

Affiliations

¹ Prenatal Diagnosis Center, Department of Clinical Laboratory, Changning Maternity and Infant Health Hospital, East China Normal University, Shanghai, 200051, China.
² Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China.
³ Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China. helin@sjtu.edu.cn.
⁴ Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China. wuxi0901@sjtu.edu.cn.

Kefu Tang et al. Sci China Life Sci. 2022 Dec.

. 2022 Dec;65(12):2560-2563.

doi: 10.1007/s11427-021-2138-7. Epub 2022 Jun 23.

¹ Prenatal Diagnosis Center, Department of Clinical Laboratory, Changning Maternity and Infant Health Hospital, East China Normal University, Shanghai, 200051, China.
² Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China.
³ Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China. helin@sjtu.edu.cn.
⁴ Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, 200030, China. wuxi0901@sjtu.edu.cn.

No abstract available

References

1. Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, Li Z, Zhou G, Gou J, Qu J, et al. COVID-19: Abnormal liver function tests. J Hepatol. 2020;73:566–574. doi: 10.1016/j.jhep.2020.04.006. - DOI - PMC - PubMed
1. Crisan D, Avram L, Grapa C, Dragan A, Radulescu D, Crisan S, Grosu A, Militaru V, Buzdugan E, Stoicescu L, et al. Liver injury and elevated FIB-4 define a high-risk group in patients with COVID-19. J Clin Med. 2021;11:153. doi: 10.3390/jcm11010153. - DOI - PMC - PubMed
1. Graupera, I., Thiele, M., Serra-Burriel, M., Caballeria, L., Roulot, D., Wong, G.L.H., Fabrellas, N., Guha, I.N., Arslanow, A., Expósito, C., et al. (2021). Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population. Clin Gastroenterol Hepatol, doi: 10.1016/j.cgh.2021.12.034. - PubMed
1. Li, J., Tian, A., Zhu, H., Chen, L., Wen, J., Liu, W., and Chen, P. (2022). Mendelian randomization analysis reveals no causal relationship between nonalcoholic fatty liver disease and severe COVID-19. Clin Gastroenterol Hepatol, doi: 10.1016/j.cgh.2022.01.045. - PMC - PubMed
1. Li Y, Regan J, Fajnzylber J, Coxen K, Corry H, Wong C, Rosenthal A, Atyeo C, Fischinger S, Gillespie E, et al. Liver fibrosis index FIB-4 is associated with mortality in COVID-19. Hepatol Commun. 2021;5:434–445. doi: 10.1002/hep4.1650. - DOI - PMC - PubMed